Stanley R. Terlecky - Publications

Wayne State University, Detroit, MI, United States 
Cell Biology, Pathology

23 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Bao B, Mitrea C, Wijesinghe P, Marchetti L, Girsch E, Farr RL, Boerner JL, Mohammad R, Dyson G, Terlecky SR, Bollig-Fischer A. Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity. Scientific Reports. 7: 44125. PMID 28281569 DOI: 10.1038/Srep44125  0.52
2016 Nell HJ, Au JL, Giordano CR, Terlecky SR, Walton PA, Whitehead SN, Cechetto DF. The targeted antioxidant, catalase-SKL, reduces beta-amyloid toxicity in the rat brain. Brain Pathology (Zurich, Switzerland). PMID 26919450 DOI: 10.1111/bpa.12368  1
2015 Giordano CR, Roberts R, Krentz KA, Bissig D, Talreja D, Kumar A, Terlecky SR, Berkowitz BA. Catalase therapy corrects oxidative stress-induced pathophysiology in incipient diabetic retinopathy. Investigative Ophthalmology & Visual Science. 56: 3095-102. PMID 25813998 DOI: 10.1167/Iovs.14-16194  0.6
2014 Giordano CR, Terlecky LJ, Bollig-Fischer A, Walton PA, Terlecky SR. Amyloid-beta neuroprotection mediated by a targeted antioxidant. Scientific Reports. 4: 4983. PMID 24828380 DOI: 10.1038/srep04983  0.6
2012 Giordano CR, Mueller KL, Terlecky LJ, Krentz KA, Bollig-Fischer A, Terlecky SR, Boerner JL. A targeted enzyme approach to sensitization of tyrosine kinase inhibitor-resistant breast cancer cells. Experimental Cell Research. 318: 2014-21. PMID 22687878 DOI: 10.1016/j.yexcr.2012.06.001  0.6
2012 Terlecky SR, Terlecky LJ, Giordano CR. Peroxisomes, oxidative stress, and inflammation. World Journal of Biological Chemistry. 3: 93-7. PMID 22649571 DOI: 10.4331/wjbc.v3.i5.93  1
2012 Giordano CR, Terlecky SR. Peroxisomes, cell senescence, and rates of aging. Biochimica Et Biophysica Acta. 1822: 1358-62. PMID 22497955 DOI: 10.1016/j.bbadis.2012.03.013  1
2009 Zhong Q, Terlecky SR, Lash LH. Diabetes increases susceptibility of primary cultures of rat proximal tubular cells to chemically induced injury. Toxicology and Applied Pharmacology. 241: 1-13. PMID 19682476 DOI: 10.1016/j.taap.2009.08.007  0.6
2009 Price M, Terlecky SR, Kessel D. A role for hydrogen peroxide in the pro-apoptotic effects of photodynamic therapy. Photochemistry and Photobiology. 85: 1491-6. PMID 19659920 DOI: 10.1111/j.1751-1097.2009.00589.x  0.6
2008 Koepke JI, Wood CS, Terlecky LJ, Walton PA, Terlecky SR. Progeric effects of catalase inactivation in human cells. Toxicology and Applied Pharmacology. 232: 99-108. PMID 18634817 DOI: 10.1016/j.taap.2008.06.004  0.6
2008 Young CN, Koepke JI, Terlecky LJ, Borkin MS, Boyd SL, Terlecky SR. Reactive oxygen species in tumor necrosis factor-α-activated primary human keratinocytes: Implications for psoriasis and inflammatory skin disease Journal of Investigative Dermatology. 128: 2606-2614. PMID 18463678 DOI: 10.1038/jid.2008.122  0.6
2007 Koepke JI, Nakrieko KA, Wood CS, Boucher KK, Terlecky LJ, Walton PA, Terlecky SR. Restoration of peroxisomal catalase import in a model of human cellular aging. Traffic (Copenhagen, Denmark). 8: 1590-600. PMID 17822396 DOI: 10.1111/j.1600-0854.2007.00633.x  0.6
2007 Terlecky SR, Koepke JI. Drug delivery to peroxisomes: employing unique trafficking mechanisms to target protein therapeutics. Advanced Drug Delivery Reviews. 59: 739-47. PMID 17659806 DOI: 10.1016/j.addr.2007.06.005  1
2006 Terlecky SR, Koepke JI, Walton PA. Peroxisomes and aging. Biochimica Et Biophysica Acta. 1763: 1749-54. PMID 17027095 DOI: 10.1016/j.bbamcr.2006.08.017  0.6
2006 Wood CS, Koepke JI, Teng H, Boucher KK, Katz S, Chang P, Terlecky LJ, Papanayotou I, Walton PA, Terlecky SR. Hypocatalasemic fibroblasts accumulate hydrogen peroxide and display age-associated pathologies. Traffic (Copenhagen, Denmark). 7: 97-107. PMID 16445690 DOI: 10.1111/j.1600-0854.2005.00358.x  0.6
2004 Logsdon BC, Vickrey JF, Martin P, Proteasa G, Koepke JI, Terlecky SR, Wawrzak Z, Winters MA, Merigan TC, Kovari LC. Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity. Journal of Virology. 78: 3123-32. PMID 14990731 DOI: 10.1128/Jvi.78.6.3123-3132.2004  0.6
2003 Brocard CB, Jedeszko C, Song HC, Terlecky SR, Walton PA. Protein structure and import into the peroxisomal matrix. Traffic (Copenhagen, Denmark). 4: 74-82. PMID 12559034 DOI: 10.1034/j.1600-0854.2003.40203.x  0.6
2002 Legakis JE, Koepke JI, Jedeszko C, Barlaskar F, Terlecky LJ, Edwards HJ, Walton PA, Terlecky SR. Peroxisome senescence in human fibroblasts. Molecular Biology of the Cell. 13: 4243-55. PMID 12475949 DOI: 10.1091/mbc.E02-06-0322  0.6
2001 Legakis JE, Terlecky SR. PTS2 protein import into mammalian peroxisomes. Traffic (Copenhagen, Denmark). 2: 252-60. PMID 11285135  1
2001 Terlecky SR, Legakis JE, Hueni SE, Subramani S. Quantitative analysis of peroxisomal protein import in vitro. Experimental Cell Research. 263: 98-106. PMID 11161709 DOI: 10.1006/excr.2000.5111  1
1998 Faber KN, Elgersma Y, Heyman JA, Koller A, Lüers GH, Nuttley WM, Terlecky SR, Wenzel TJ, Subramani S. Use of Pichia pastoris as a model eukaryotic system. Peroxisome biogenesis. Methods in Molecular Biology (Clifton, N.J.). 103: 121-47. PMID 9680638 DOI: 10.1385/0-89603-421-6:121  0.6
1996 Terlecky SR, Wiemer EAC, Nuttley WM, Walton PA, Subramani S. Signals, receptors, and cytosolic factors involved in peroxisomal protein import Annals of the New York Academy of Sciences. 804: 11-20. PMID 8993532 DOI: 10.1111/j.1749-6632.1996.tb18604.x  0.6
1989 Chiang HL, Terlecky SR, Plant CP, Dice JF. A role for a 70-kilodaton heat shock protein in lysosomal degradation of intracellular proteins Science. 246: 382-385. PMID 2799391 DOI: 10.1126/SCIENCE.2799391  0.6
Show low-probability matches.